Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$994M |
| 2 |
Cigna
CI
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$395M |
| 4 |
Amazon
AMZN
|
+$281M |
| 5 |
CVS Health
CVS
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$918M |
| 2 |
AET
Aetna Inc
AET
|
+$761M |
| 3 |
PX
Praxair Inc
PX
|
+$581M |
| 4 |
COL
Rockwell Collins
COL
|
+$274M |
| 5 |
CA
CA, Inc.
CA
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.41% |
| 3 | Healthcare | 13.78% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Spyre Therapeutics
SYRE
$8.93B
| $1.37M | ﹤0.01% |
7,310
+37
| +0.5% | +$7.85K |
|
|
PAMT
3252
PAMT Corp
PAMT
$288M
| $1.37M | ﹤0.01% |
138,720
-3,596
| -3% | -$47.4K |
|
|
BLCM
3253
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.36M | ﹤0.01% |
46,706
-2,133
| -4% | -$94.6K |
|
|
DOVA
3254
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $1.36M | ﹤0.01% |
179,018
-99
| -0.1% | -$1.59K |
|
3255
eGain
EGAN
$205M
| $1.35M | ﹤0.01% |
206,034
-3,059
| -1% | -$22.2K |
|
|
KZR
3256
DELISTED
Kezar Life Sciences
KZR
| $1.34M | ﹤0.01% |
5,699
+458
| +9% | +$112K |
|
|
USX
3257
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.33M | ﹤0.01% |
237,144
+899
| +0.4% | +$7.55K |
|
3258
Canadian Solar
CSIQ
$1.08B
| $1.32M | ﹤0.01% |
92,311
+1,596
| +2% | +$24.1K |
|
|
TECX
3259
Tectonic Therapeutic
TECX
$632M
| $1.32M | ﹤0.01% |
6,601
+181
| +3% | +$55.1K |
|
3260
First Community Corp
FCCO
$318M
| $1.32M | ﹤0.01% |
67,759
+663
| +1% | +$14.7K |
|
|
UBFO
3261
DELISTED
United Security Bancshares
UBFO
| $1.3M | ﹤0.01% |
136,218
+525
| +0.4% | +$5.51K |
|
3262
MVB Financial
MVBF
$393M
| $1.3M | ﹤0.01% |
72,111
-520
| -0.7% | -$9.49K |
|
|
EIDX
3263
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.3M | ﹤0.01% |
94,601
+4,594
| +5% | +$58K |
|
3264
Gaia
GAIA
$32.4M
| $1.3M | ﹤0.01% |
125,394
-1,015
| -0.8% | -$13.4K |
|
|
AMRS
3265
DELISTED
Amyris Inc.
AMRS
| $1.3M | ﹤0.01% |
387,984
+27,152
| +8% | +$156K |
|
3266
PagSeguro Digital
PAGS
$2.51B
| $1.29M | ﹤0.01% |
69,049
-1,412
| -2% | -$34.6K |
|
|
AMR
3267
DELISTED
Alta Mesa Resources Inc
AMR
| $1.29M | ﹤0.01% |
1,294,363
-21,783
| -2% | -$55.1K |
|
|
GFN
3268
DELISTED
General Finance Corporation
GFN
| $1.29M | ﹤0.01% |
127,666
+15,597
| +14% | +$203K |
|
|
ODT
3269
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.29M | ﹤0.01% |
91,550
+9,125
| +11% | +$142K |
|
3270
ProShares Short S&P500
SH
$845M
| $1.28M | ﹤0.01% |
+10,214
| New | +$1.2M |
|
|
FLNT
3271
Fluent
FLNT
$122M
| $1.28M | ﹤0.01% |
59,137
+312
| +0.5% | +$5.69K |
|
|
CMRX
3272
DELISTED
Chimerix, Inc.
CMRX
| $1.28M | ﹤0.01% |
496,586
-1,233
| -0.2% | -$4.13K |
|
3273
Brookfield Renewable
BEP
$10.1B
| $1.27M | ﹤0.01% |
92,309
+24,847
| +37% | +$372K |
|
3274
Peoples Bancorp of North Carolina
PEBK
$233M
| $1.27M | ﹤0.01% |
52,103
-558
| -1% | -$15.3K |
|
3275
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $1.27M | ﹤0.01% |
12,245
+3,270
| +36% | +$342K |
|
Similar funds
Northern Trust's Q4 2018 Portfolio in Review
As of Q4 2018, Northern Trust held 4,401 positions worth $357B, down 13% from $409B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 5%. Northern Trust opened 95 new positions and exited 125, leaving the 4,401-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2018 buy was Linde: 6,288,266 shares worth $981M.
- Northern Trust added most to Cigna in Q4 2018, an estimated $524M increase.
- Northern Trust's biggest Q4 2018 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $224M.
- Northern Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $918M.
- Northern Trust's ten largest holdings make up 16% of its $357B portfolio in Q4 2018.
- Northern Trust opened 95 new positions and closed 125 in Q4 2018.
- Northern Trust's portfolio value fell 13% quarter-over-quarter to $357B.
Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.